Healthcare -
Biotechnology - NASDAQ - CA
$ 1.17
-3.31 %
$ 5.13 M
Market Cap
-0.69
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Clearmind Medicine Inc.
| Revenue | 0 |
| Cost Of Revenue | 26.7 K |
| Gross Profit | -26.7 K |
| Operating Expenses | 5.72 M |
| Operating Income | -6.3 M |
| Other Expenses | -1.05 M |
| Net Income | -5.25 M |
Income Statement
Millions
| Oct-2024 | Oct-2023 | Oct-2022 | Oct-2021 | Oct-2020 | Oct-2019 | Oct-2018 | Oct-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 26.7 K | 56.3 K | 0.1 | 2.57 K | 0 | 0 | 0 | 0 |
| Gross Profit | 26.7 K | 56.3 K | (0.1) | 2.57 K | 0 | 0 | 0 | 0 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 5.7 | 8.7 | 8.5 | 3.7 | 0.2 | 0.1 | 0.3 | 6.67 K |
| Selling, General and Administrative Expenses | 4.4 | 6.6 | 5.4 | 3.0 | 0.2 | 0.1 | 0.3 | 6.67 K |
| Research and Development Expenses | 1.4 | 2.1 | 3.0 | 0.6 | 0 | 0 | 0 | 0 |
| Operating Income | (6.3) | (8.7) | (8.5) | (3.5) | (0.2) | (0.1) | (0.3) | 6.67 K |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 36.2 K | 0 | 19.7 K | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 1.0 | (3.2) | (0.8) | 43.5 K | (0.2) | 0 | 60 K | 1 |
| Pre-Tax Income | (4.9) | (11.9) | (9.4) | (3.9) | (0.2) | (0.1) | (0.2) | 6.67 K |
| NET INCOME | ||||||||
| Tax Provision | 0.4 | 24.1 K | 40.8 K | 0.2 | (0.4) | (0.2) | 60 K | 0 |
| Net Income | (5.3) | (12.0) | (9.4) | (4.1) | (0.2) | (0.1) | (0.2) | 6.67 K |
| EPS | 1.7 | 42.6 | 169 | 95.7 | 9.56 | 6.42 | 14 | 0.42 |